| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
MDL 72274A manufacturers
- MDL-72274 HCl
-
- $1520.00
-
2026-04-20
- CAS:85278-24-6
- Purity:
- Supply Ability: 10g
|
| | MDL 72274A Basic information |
| Product Name: | MDL 72274A | | Synonyms: | MDL72274 HCl;MDL 72274A;(E)-beta-(Chloromethylene)benzeneethanamine hydrochloride;Beta-(Chloromethylene)benzeneethanamine hydrochloride;MDL72274; MDL-72274; MDL 72274; MDL72274A; MDL-72274A; MDL 72274A; MDL72274 HCL;MDL 72274 HCl,MDL72274 HCl;(e)-3-chloro-2-phenylprop-2-en-1-amine hydrochloride | | CAS: | 85278-24-6 | | MF: | C9H10ClN.ClH | | MW: | 204.1 | | EINECS: | | | Product Categories: | | | Mol File: | 85278-24-6.mol |  |
| | MDL 72274A Chemical Properties |
| storage temp. | Store at 0-8 °C | | Appearance | white solid |
| | MDL 72274A Usage And Synthesis |
| Description | MDL-72274 HCl is selective and potent inhibitors of SSAO for treatment of Parkinson diseases. MDL-72974 is a potent (IC50 = 10(-9) M) inhibitor of both MAO-B and SSAO, with 190-fold lower affinity for MAO-A. In clinical studies, oral doses as low as 100 micrograms produced substantial inhibition of platelet MAO-B. One or 4 mg MDL-72274 HCl given daily for 28 days to 40 Parkinson's patients treated with L-dopa produced statistically significant reductions in the Unified Parkinson's Disease Rating Scale. MAO-B inhibitors, such as MDL 72974A and L-deprenyl, offer the potential of being neuroprotective in Parkinson's Disease and other neurogenerative disorders. |
| | MDL 72274A Preparation Products And Raw materials |
|